Complementary and Alternative Interventions for Veterans With Posttraumatic Stress Disorder

University of Wisconsin, Madison70 enrolled

Overview

The overarching aim of this proposal is to research whether meditation-based treatments are effective in decreasing posttraumatic stress disorder (PSTD) symptoms in veterans, which complementary and alternative (CA) treatments are most effective, and how individual differences predict treatment efficacy.

The overarching purpose of this study is to assess the impact of CA interventions on posttraumatic stress symptoms in veterans with PTSD. Twenty percent of the approximately 2 million veterans returning from Iraq and Afghanistan ("Operation Iraqi Freedom" or OIF and "Operation Enduring Freedom" or OEF) suffer from the symptoms of Post-traumatic Stress Disorder. PTSD may be the reason behind alarming increases in suicidal behavior among returning veterans in Wisconsin and nation-wide. In addition to traditional treatments, Veterans Administration (VA) Hospitals and other community institutions for veterans now offer CA programs to their patients. Past research from our laboratory and others suggests that CA programs may provide effective relief from anxiety while increasing psychological well-being. However, little research exists on the effects of CA programs for combat veterans with PTSD. The proposed study aims to address this important gap by assessing CA programs such as Sudarshan Kriya Yoga (SKY) and Mindfulness-Based Stress Reduction (MBSR). 150 veterans with PTSD will be randomly assigned to either SKY, MBSR, or the wait-list control (WLC) group. We will assess participants' PTSD symptoms pre-intervention, post-intervention (approximately 10-14 days after initial visit), and 1 month post-treatment (approximately 6 weeks after initial visit). In order to evaluate the programs' effects as comprehensively as possible, we propose a multi-method approach: baseline psychophysiology, autonomic reactivity and recovery, neuropsychological (cognitive) assessments, self-report questionnaires, and functional brain imaging (fMRI). Baseline measures will be collected from a group of 50 combat-exposed veterans without PTSD to assess group differences on these measures prior to treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

PTSD

Interventions

Sudarshan Kriya YogaBEHAVIORAL

SKY incorporates yoga, discussion periods and several types of breathing exercises for relaxation.

Mindfulness-Based Stress ReductionBEHAVIORAL

MBSR incorporates yoga, discussion periods, and several types of meditation, all involving attention to the present moment and acceptance of any feelings, sensations or thoughts

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * In the age range of 18-50. * Capable of giving informed consent * Fluent in English * Exposure to one or more life-threatening war zone trauma events in Iraq or Afghanistan within the last 8 years. * Pharmacological or psychotherapeutic treatment stable for at least 8 weeks prior to beginning of study * Good general medical health (see Medical Exclusion Criteria) * DSM-IV criteria for current PTSD as determined by CAPS (PTSD groups only) * Combat-exposed, non-PTSD control veterans must be free of any current DSM-IV Axis I disorder * Participants must agree to not begin a new course of treatment for the duration of the study Exclusion Criteria: * Weight of 352 pounds or over (due to constraints of MRI scanner) * Women who are pregnant, planning to conceive during the research timeline, or breastfeeding will be excluded. * Metallic implants such as prostheses or aneurysm clip, or electronic implants such as cardiac pacemakers * Neurological or serious medical condition that may contraindicate MRI or that may overlap with physiological substrates of psychiatric conditions (see below for descriptions) * History of seizures or seizure disorder * Moderate or severe traumatic brain injury (over 30 minutes unconscious) * Current active substance dependence or dependence within 3 months (other than nicotine) * Meets DSM-IV criteria for bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder NOS, delirium, or any DSM-IV cognitive disorder. * Substance dependence disorder within 3 months or any current substance dependence * Severe psychiatric instability or severe situational life crises, including evidence of being actively suicidal or homicidal, or any behavior that poses an immediate danger to patient or others. * Current use of benzodiazepines or beta-blockers * Nonsuicidal depression comorbid with PTSD will NOT be exclusionary * Extensive experience in yoga and meditation or have learned MBSR or SKY previously

Locations (1)

Waisman Center, University of Wisconsin

Madison, Wisconsin, United States

Outcomes

Primary Outcomes

Change in Clinician-Administered PTSD Scale (CAPS) scores

Time frame: Baseline, 1 month post-intervention (approx. 6 weeks)

Change in PTSD Checklist-Military (PCL-M) scores

Time frame: Baseline, Post-Intervention (approx. 10-14 days), 1 month post-intervention (approx. 6 weeks)

Change in fMRI brain blood oxygen level-dependent (BOLD) responses

Brain activation during anticipation of, response to, and recovery from aversive stimuli will be measured at baseline, and the intervention groups will be compared to the wait-list controls following the intervention to assess changes based on the interventions.

Time frame: Baseline, post-intervention (approx 10-14 days)

Secondary Outcomes

Quality of sleep

Sleep quality will be assessed using actigraphy

Time frame: Baseline through one month post-intervention (approx. 6 weeks)

Changes in self-reported mood, anxiety, and sleep symptoms

Time frame: Baseline, post-intervention (approx. 10-14 days), one month post-intervention (approx. 6 weeks)

Changes in peripheral psychophysiological arousal

Assessed using multiple measures, including heart rate, heart rate variability, corrugator EMG, and skin conductance.

Time frame: Baseline and post-intervention (approx. 10-14 days)

Changes in neuropsychological functioning

Memory, attention, and rapid perceptual processing will be measured using neuropsychological tasks by Cambridge Cognition and/or the NIH toolbox

Time frame: Baseline, post-intervention (approx. 10-14 days)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.